Where does Gfbiochemicals Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Gfbiochemicals Limited ranks #24,397 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Gfbiochemicals Limited hold?

Gfbiochemicals Limited holds 11 US utility patents granted between 2016 and 2019, spanning 15 technology areas.

What is Gfbiochemicals Limited's Innovation Score?

Gfbiochemicals Limited has an Innovation Score of 34.3 out of 100 (47th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Gfbiochemicals Limited focus on?

Gfbiochemicals Limited's top technology area is C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients) with 6 patents, ranking #487 of 1,963 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is Gfbiochemicals Limited's patent grant rate increasing or decreasing?

Gfbiochemicals Limited's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Gfbiochemicals Limited's patents?

Gfbiochemicals Limited's patents average 20.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Gfbiochemicals Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Gfbiochemicals Limited

USPTO PatentsView assignee record - 11 granted patents across 15 technology areas, recorded in grant years 2016–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gfbiochemicals ranks #24,397 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 15 technology areas.

#24,397
of 49,997 US assignees by volume: 47th percentile
by Innovation Score (34.3/100): 20.0
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R24397 · Foreign Corporation #24,397 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #24,397/49,997
PHOTO-FINISH GE Oil & Gas
CPC-FOCUS C08K · 15 areas
INNOV-THIN 34.3/100
CLAIMS-DENSE 20.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: GE Oil & Gas, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Gfbiochemicals’s 34.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (25%) Velocity 0.0 pts (0%) Breadth 13.7 pts (40%) Claim depth 12.0 pts (35%)

Qualcomm Incorporated · highest

85
Gfbiochemicals · this assignee

34
3D Lighting… · lowest

7

What this shows Gfbiochemicals's Innovation Score is 34.3/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Gfbiochemicals?

Each dot is one of Gfbiochemicals’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Gfbiochemicals’s own 20.0 claims/patent is ABOVE the 13.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Gfbiochemicals vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Gfbiochemicals's grants concentrate

Gfbiochemicals Limited is a focused PatentsView assignee: 15 CPC subclasses with 54.5% of grants classified under C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients). Peak complete grant year is 2017 (6 grants) versus a trough of 1 in 2019. By volume, Gfbiochemicals sits between GE Oil & Gas, Inc. and GO NET Systems Ltd.

GE Oil & Gas

11
Gemu Gebr Mueller…

11
Gentos

11
GET Fabric

11
GFL

11
Giftcodes COM

11
Global Health Sol…

11
GO NET Systems

11
Gfbiochemicals ◀

11

What this shows Gfbiochemicals holds 11 patents at rank #24,379, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Gfbiochemicals

By rank, the assignees closest to #24,379 in granted patent volume.

Leaders in C08K (Use of inorganic or non-macromolecular organic substances…)

Other assignees with the most granted patents in Gfbiochemicals's primary technology class.

Gfbiochemicals's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Gfbiochemicals Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	18.2%
2017	6	54.5%
2018	2	18.2%
2019	1	9.1%

Which technologies does Gfbiochemicals Limited patent most?

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 6

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 5

C07D - Heterocyclic Compounds 5

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

C07C - Acyclic OR Carbocyclic Compounds 2

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

C08L - Compositions OF Macromolecular Compounds 1

Y10T - Technical Subjects Covered BY Former US Classification 1

B01D - Separation 1

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Gfbiochemicals Limited's patent record in context - here's where to go next.

Gfbiochemicals Limited's lead technology class is C08K (Use of inorganic or non-macromolecular organic substances as compounding ingredients), 54.5% of its portfolio - see every assignee active in that class. Explore C08K
Ranked #24,397 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Gfbiochemicals Limited against GE Oil & Gas, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.